P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES

Atalar S. C.

HemaSphere, vol.6, pp.1114-1115, 2022 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 6
• Publication Date: 2022
• Doi Number: 10.1097/01.hs9.0000847780.61937.3d
• Journal Name: HemaSphere
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
• Page Numbers: pp.1114-1115
• Istanbul University Affiliated: No